Marker Therapeutics Inc Financial Flexibility Index
Marker Therapeutics Inc financial flexibility index. Marker Therapeutics Inc (MRKR) has a Financial Flexibility Index of -1.54x as of June 2026. Free cash flow of $-3.72 Million (operating CF $-3.72 Million minus capex $0.00) represents -2% of total liabilities ($2.42 Million). See MRKR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Marker Therapeutics Inc (1999–2025)
Financial flexibility index of Marker Therapeutics Inc from 1999 to 2025. Historical Financial Flexibility Index trend for Marker Therapeutics Inc across 27 annual periods. Check MRKR cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Marker Therapeutics Inc Financial Flexibility Index by Year (1999–2025)
Marker Therapeutics Inc financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Marker Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Marker Therapeutics Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.28x | $-12.01 Million | $-12.01 Million | $2.27 Million | ▼ -67.7% |
| 2024 | -3.15x | $-10.91 Million | $-10.91 Million | $3.46 Million | ▲ +41.1% |
| 2023 | -5.35x | $-16.44 Million | $-16.44 Million | $3.07 Million | ▼ -193.8% |
| 2022 | -1.82x | $-26.97 Million | $-26.97 Million | $14.82 Million | ▼ -82.0% |
| 2021 | -1.00x | $-24.15 Million | $-27.28 Million | $24.15 Million | ▼ -69.4% |
| 2020 | -0.59x | $-10.78 Million | $-20.03 Million | $18.27 Million | ▲ +92.5% |
| 2019 | -7.88x | $-17.91 Million | $-18.28 Million | $2.27 Million | ▼ -54.1% |
| 2018 | -5.11x | $-14.33 Million | $-14.48 Million | $2.80 Million | ▲ +6.1% |
| 2017 | -5.45x | $-8.29 Million | $-8.44 Million | $1.52 Million | ▼ -48.7% |
| 2016 | -3.66x | $-6.36 Million | $-6.51 Million | $1.74 Million | ▼ -2345.1% |
| 2015 | -0.15x | $-4.20 Million | $-4.34 Million | $28.01 Million | ▲ +91.5% |
| 2014 | -1.75x | $-2.19 Million | $-2.19 Million | $1.25 Million | ▼ -2131.6% |
| 2013 | -0.08x | $-694.58K | $-694.58K | $8.85 Million | ▲ +71.0% |
| 2012 | -0.27x | $-1.57 Million | $-1.57 Million | $5.77 Million | ▲ +21.3% |
| 2011 | -0.34x | $-1.31 Million | $-1.31 Million | $3.80 Million | ▼ -26.3% |
| 2010 | -0.27x | $-925.04K | $-925.04K | $3.39 Million | ▲ +76.0% |
| 2009 | -1.14x | $-1.12 Million | $-1.12 Million | $986.35K | ▼ -405.6% |
| 2008 | -0.22x | $-692.00K | $-714.42K | $3.08 Million | ▲ +63.5% |
| 2007 | -0.62x | $-1.20 Million | $-1.23 Million | $1.95 Million | ▼ -63.8% |
| 2006 | -0.38x | $-1.19 Million | $-1.19 Million | $3.15 Million | ▲ +25.3% |
| 2005 | -0.50x | $-1.16 Million | $-1.16 Million | $2.31 Million | ▼ -4.8% |
| 2004 | -0.48x | $-1.21 Million | $-1.21 Million | $2.53 Million | ▲ +86.3% |
| 2003 | -3.51x | $-2.59 Million | $-2.59 Million | $736.95K | ▲ +25.9% |
| 2002 | -4.74x | $-1.40 Million | $-1.41 Million | $295.60K | ▼ -34597.9% |
| 2001 | 0.01x | $2.38K | $2.38K | $173.03K | ▲ +101.1% |
| 2000 | -1.28x | $-876.88K | $-879.74K | $682.74K | ▲ +51.1% |
| 1999 | -2.63x | $-761.15K | $-815.18K | $289.71K | — |